Our findings provide new insight about the role of PC-1 and 4E-BP1 in cellular physiology and PCa progression and imply that PC-1-4E-BP1 interactions might be an excellent therapeutic target for advanced PCa. The gene discussed is EIF4EBP1; the disease is posterior cortical atrophy.